Latest News about KYMR

Recent news which mentions KYMR

< Previous 1 2 3 4 Next >

During the second quarter, Kymera Therapeutics (KYMR) reported an 8-cent decline in earnings per share

August 12, 2022

5 Analysts Have This to Say About Kymera Therapeutics

August 10, 2022

Kymera Therapeutics: Q2 Earnings Insights

August 09, 2022

Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2022

August 03, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2022

July 20, 2022

Kymera Therapeutics Commences Initial-Stage Oncology Trials

June 15, 2022

The Daily Biotech Pulse: FDA Committee Backs Moderna Shot For 5-17 Years, 180 Life Sciences Stock Plunges, Pfizer's Posts Disappointing Paxlovid Data

June 15, 2022

Why Kymera Therapeutics Stock Is Gaining Wednesday

June 01, 2022

Analyst Ratings for Kymera Therapeutics

June 01, 2022

Fresh Del Monte Produce And 2 Other Stocks Insiders Are Buying

June 01, 2022

3 Biotech Stocks to Buy Before They Boom

June 01, 2022

Executives Buy Around $141M Of 4 Stocks

May 10, 2022

81 Biggest Movers From Yesterday

May 05, 2022

50 Stocks Moving In Wednesday's Mid-Day Session

May 04, 2022

80 Biggest Movers From Yesterday

May 04, 2022

Mid-Afternoon Market Update: Kymera Therapeutics Drops After Q1 Results; Belite Bio Shares Spike Higher

May 03, 2022

Why Kymera Therapeutics Shares Are Falling Today

May 03, 2022

12 Health Care Stocks Moving In Tuesday's Intraday Session

May 03, 2022

Why Kymera Therapeutics Stock Is Getting Hammered Today

May 03, 2022

Mid-Day Market Update: Dow Jumps 100 Points; Spero Therapeutics Shares Plunge

May 03, 2022

41 Stocks Moving In Tuesday's Mid-Day Session

May 03, 2022

Kymera Therapeutics: Q1 Earnings Insights

May 03, 2022

Analyst Ratings for Kymera Therapeutics

April 28, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2022

April 28, 2022

Kymera Therapeutics Q1 2022 Earnings Conference Call On May 3, 2022 At 08:00 AM ET

April 21, 2022

10 Health Care Stocks Whale Activity In Today's Session

March 18, 2022

JPMorgan Sees 'Limited Upside Potential' In Kymera Therapeutics' KT-474

March 10, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 10, 2022

March 10, 2022

3 Cutting-Edge, Protein-Degrader Biotech Stocks to Watch

February 16, 2022

Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2022

February 10, 2022

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.